A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta)
- 15 July 2003
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 373 (2), 393-401
- https://doi.org/10.1042/bj20021851
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Steric Hindrance as a Basis for Structure-Based Design of Selective Inhibitors of Protein-Tyrosine PhosphatasesBiochemistry, 2001
- Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase DomainsMolecular and Cellular Biology, 2001
- βiv Spectrin, a New Spectrin Localized at Axon Initial Segments and Nodes of Ranvier in the Central and Peripheral Nervous SystemThe Journal of cell biology, 2000
- The receptor tyrosine phosphatase-like protein ICA512 binds the PDZ domains of β2-syntrophin and nNOS in pancreatic β-cellsEuropean Journal of Cell Biology, 2000
- Residue 259 Is a Key Determinant of Substrate Specificity of Protein-tyrosine Phosphatases 1B and αPublished by Elsevier ,2000
- Structure-based Design of a Low Molecular Weight, Nonphosphorus, Nonpeptide, and Highly Selective Inhibitor of Protein-tyrosine Phosphatase 1BJournal of Biological Chemistry, 2000
- 2-(Oxalylamino)-Benzoic Acid Is a General, Competitive Inhibitor of Protein-tyrosine PhosphatasesPublished by Elsevier ,2000
- Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetesDiabetologia, 1999
- WHAT IF: A molecular modeling and drug design programJournal of Molecular Graphics, 1990
- The protein data bank: A computer-based archival file for macromolecular structuresJournal of Molecular Biology, 1977